chrisvoncsefalvay/vaers-outcomes huggingface dataset:
HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. The batch number was not reported. Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 25-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from headache. This report was non-serious.
Pfizer 4/1/21, 4/26/21, 11/15/21. Positive on 12/22/22
hands and palms were also painful, itching; Sensitive to warm water; Itching; red rash on his back, buttocks, arms, hands and palms; This case was reported by a consumer via call center representative and described the occurrence of pruritus in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included meat allergy. Concomitant products included prednisone.   On 12th December 2019, the patient received the 1st dose of Shingrix (intramuscular). In December 2019, 7 days after receiving Shingrix, the patient experienced pruritus. In February 2020, the patient experienced red rash, pain in extremity and sensitization. The patient was treated with hydrocortisone (Cortisone Topical Cream) and benadryl (nos) (Benadryl). On an unknown date, the outcome of the pruritus and red rash were recovered/resolved and the outcome of the pain in extremity and sensitization were unknown.   It was unknown if the reporter considered the pruritus, red rash, pain in extremity and sensitization to be related to Shingrix.  Additional details were provided as follows: After receiving Shingrix, the patient experienced itching. The patient also experienced red rash on his back, buttocks, arms, hands and palms. His hands and palms were also painful, itching, and sensitive to warm water. The patient used topical cortisone and prescription cream. When he initially noticed the rash he took Benadryl. The day after he noticed the rash, he visited his physician assistant, and had blood work done for an allergy test. The results showed that he was allergic to alphagalactose. He also saw his allergist and was told to stop eating red meat and carry an EpiPen with him.      Lab Comments: On an unknown date, lab test was performed
Information has been received from a pharmacy intern referring to a male patient of unknown age. The patient's medical history, concurrent condition and concomitant therapy were not reported. On an unknown date in January 2017, the patient was vaccinated with ZOSTAVAX (dose, lot #, expiration date and route not reported) for prophylaxis. On an unknown date in 2017, the patient had low titre to varicella. The patient was on a "organ transplant list" for an unknown reason. The outcome of the events was unknown. Causality assessment was not provided. Upon internal review, the event "the patient was on a organ transplant list for an unknown reason" was considered to be medically significant as the patient might need organ transplant.
No additional AE; Nurse reported an expired dose of V AQT A was administered to a patient; This spontaneous report was received from a nurse referring to a 57 years old male patient. The patient's medical history, concurrent conditions, historical drugs and concomitant medications were unknown.  On 28-OCT-2021, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) (lot # T017179, expiration date 26-OCT-2021; strength, dose, route were not reported) once in right arm for prophylaxis (expired product administered). No events have occurred at this time as a result of the expired vaccine administration. The patient has not sought any medical treatment. The reporter had no additional information at this time (no adverse event).
Depression; All my exams started to change; very disappointed and living hell; This is a spontaneous report from a contactable Healthcare professional (Physician) (patient, self-reported). A patient of an unspecified age and gender received a dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified, the patient wanted to say that the patient was going to file an investigation against everything that's going on. When the patient was chose Pfizer it was because you said the vaccine was good for patients and cancer, chronic diseases. The patient lived working paying bills and taking care of children until the day the patient got this vaccine and then all the patient's exams started to change. The patient was very disappointed and living hell and even depression because of the health. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Caller reporting temperature excursion. Vaccine has been administered. No PQC. No additional information.; This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. No information on patient's medical history, current conditions and concomitant medications was provided.  On 12-OCT-2023 the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) lot # X006982 and expiration date 07-MAR-2025, 0.5 milliliter for prophylaxis (dose number, route and site of administration were not provided) (product storage error).
Received vaccine at age of 16; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received vaccine at age of 16) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received vaccine at age of 16). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received vaccine at age of 16) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-193787 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: The patient details and action taken were updated.
Fever 100.8 (duration 7 hours despite treatment with ibuprofen), severe muscle pain, shaking chills, nausea, severe headache, lethargy (duration 7 hours). Resolved after about 9 hours.
4.10.21 within 24 hours of receiving the shot, menstral period when wasn't due to start, heavy flow of blood, major blood clots never had this type of period before and only lasted a day. Normal periods 7 days and not heavy. 4.11.21 numbing / heavy sensation on left side of face and body. USA hault on J&J due to blood clots  4.13.21 urgent care, blood work ordered (can, rtc, tmr) referral to neurology 4.15.21 head CT, urgent care again for numbness and tingling left side body 4.16.21 HITP panel, D-dimer blood work 4.19.21 dr video visit review tests all ok keep referral to neurology 4.23.21 neurologist MRI with contrast no major disease noted and no sign of venous thrombosis from J&J vaccine. MAy started noticing s In May 2021 a little over a month since vaccine, started noticing it was hard to breathe with mask. Had such a difficulty had to refrane from helping at work in the cleaning needs. Addressed with Dr when could get a appointment July 23rd. Dr PA, she ordered XR chest 2 views, CBC with auto diff, CMP panel with GFR, D-Dimer, EKG 7.30.21 all tests came back within normal limits. waiting to hear back for a Pulmonary Function test. 11.8.21 hemoglobin taken for pre PFT requirement. 11.15.21 PFT performed all within normal limits 12.21.21 Stress Echocardiogram will be performed as still feel short of breath can hardly wear masks and breathe well. Didn't have a problem with the wearing of masks prior to vaccine. Also 1.21.22 will be having a consult with Pulmonologist to see what can be causing this feeling like I can't get a good breath in.
I got my 1st dose vaccine on 08/13/2021 and felt good. I was in bodega bay that weekend and it was a  bit chilly and windy and the next day I started to have migraines, my head felt heavy, a few days later my throat felt itchy with a little cough, I took a Ibuprofen and use salon pas to help with my migraines. Today sunday 08/22 I took a nap and woke up to my right arm and right leg numb ( felt like I slept on it ) felt like I couldnt move it, felt like I was paralyzed but still had feelings  but couldnt lift up my arm and leg. I felt like i was grasping for air ( like I was drowning ) and couldnt talk for a good 5 minutes. My husband helped me elevate my right arm and right leg with pillows while my daughters massage my arm and leg to help blood circulate. After 5 minutes I could finally moved my right arm and right legs.
breakouts of Herpes zoster after complete scheme of Shingrix/ Suspected vaccination failure; breakouts of Herpes zoster on the lips and on the lumbar area; This serious case was reported by a physician via call center representative and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included herpes zoster (recovered in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, more than 2 years after receiving Shingrix and Shingrix, the patient experienced vaccination failure (Verbatim: breakouts of Herpes zoster after complete scheme of Shingrix/ Suspected vaccination failure) (serious criteria GSK medically significant) and herpes zoster (Verbatim: breakouts of Herpes zoster on the lips and on the lumbar area). The outcome of the vaccination failure was unknown and the outcome of the herpes zoster was not resolved.   It was unknown if the reporter considered the vaccination failure and herpes zoster to be related to Shingrix and Shingrix.   It was unknown if the company considered the vaccination failure and herpes zoster to be related to Shingrix and Shingrix.   Additional Information: GSK Receipt Date: 19-OCT-2023 The retired physician called to inform that they recovered from Herpes zoster in 2018. After the recovery, they got the complete scheme of Shingrix. The suspect vaccine start date reported was around 2018. Now in 2023, they had been having breakouts of Herpes zoster on the lips and on the lumbar area. This case was considered as suspected vaccination failure as details regarding laboratory confirmation regarding shingles were unknown at the time of reporting. The reporter consented to follow up.
3 - 4 hours after shot patient got runny nose, cough, fever, vomiting, diarrhea, had difficulty swallowing. Felt better in 24 hours.
Patient presented to the ER after a suicide attempt  via drug overdose. Vitals in the emergency department blood pressure 178/102 heart rate 85 afebrile respiratory rate 18 pulse ox 99 on room air.  Labs on admission white cell count 3.2 lymphocytes elevated at COVID-19 screen positive.  Urine drug screen positive for cocaine.  UA negative for infection. chest  X-ray hyperinflation of the lung indicating COPD, suspicion of small amount of pneumoperitoneum,  no pneumothorax.  Subsequently patient had x-ray abdomen showed no evidence of pneumoperitoneum,  Patient was admitted for covid 19 precaution isolation .
Petechial rash noted on both upper legs (thighs) after receiving Pediarix left leg, Hib and Prevnar in right leg. Child taken to ER , admitted for 3 day admission for R/O sepsis (child afebrile).
Patient admitted on 08/26 diagnosed with COVID on 08/23. Presented to the hospital with sob, syncope and weakness.  DX with COVID PNA, hypoxia, syncope and Afib RVR. also with a PMHx of MS and on fingolimod. Patient continued to decompensate and expired on 09/10/12
Abdominal pain, joint pain. Joint pain lasted 24 hrs or so. Abdominal pain has slowly subsided but still feeling it. Planning to make a Dr?s visit but delayed due to looking for a new provider.
sore left arm for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore left arm for a couple of days) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation (cardiac issues) since 2018, Latex allergy (sensitive to latex.) and Drug allergy (sensitive to morphine.). Concomitant products included APIXABAN (ELIQUIS), METOPROLOL, AMIODARONE, ZINC and COLECALCIFEROL (VITAMIN D3) for an unknown indication.    On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jan-2021, the patient experienced MYALGIA (sore left arm for a couple of days). On 02-Jan-2021, MYALGIA (sore left arm for a couple of days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.   This case was linked to MOD-2022-542338, MOD-2022-542339 (Patient Link).
Patient has red, painful, swollen rash that started below the injection site and is moving down her arm.  Pt was prescribed keflex and prednisone.
pt recv vax & devel an inj site rxn characterized by swelling, redness & pain;
Headache, Myalgia, Diarrhea, Chills Narrative: Received 2nd dose on 1/20/21. Awoke on 1/21/21 with myalgias, significant chills but no fever, headache and some diarrhea. Slept all day 1/21/21 and felt better by 1700. Missed work x 1 day. No known prior COVID infection.
ACUTE RESPIRATORY FAILURE 5/20/2022 ATRIAL FIBRILLATION W RAPID VENTRICULAR RESPONSE
swollen right armpit; redness around injection site which the skin was hot to the touch; headache; body aches; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199), via an unspecified route of administration in the right arm on 25Mar2021 at 13:30 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medication was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318), via an unspecified route of administration in the right arm on 04Mar2021 at 11:30 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Mar2021 at 18:00, after the second dose, the patient experienced headache and body aches which started by the evening. On 27Mar2021, the patient experienced swollen right armpit and redness around injection site which the skin was hot to the touch. The patient continued to feel body aches. The patient did not receive any treatment for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, body aches, swollen right armpit and redness around injection site were resolved on 28Mar2021.  No follow-up attempts are needed. No further information is expected.
Strong metallic taste in mouth started about 20 minutes after injection - will wait to see how long it lasts
I just don´t feel good (after second dose); very itchy (after first dose and second dose); chills (after first dose)/ chills (after second dose); nausea (after first dose)/ nausea (after second dose); fever 101.7 (after first dose)/ fever 101.7 (after Second dose); Very bad pain in my stomach in the right side (after first dose and second dose); dry heave(after first dose)/ dry heave(after second dose); achy (after first dose)/ achy (after second dose); This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Very bad pain in my stomach in the right side (after first dose and second dose)), RETCHING (dry heave(after first dose)/ dry heave(after second dose)), PAIN (achy (after first dose)/ achy (after second dose)), FEELING ABNORMAL (I just don´t feel good (after second dose)) and PRURITUS (very itchy (after first dose and second dose)) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. O14M2OA and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included BUSPIRONE for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Very bad pain in my stomach in the right side (after first dose and second dose)), RETCHING (dry heave(after first dose)/ dry heave(after second dose)), PAIN (achy (after first dose)/ achy (after second dose)), PRURITUS (very itchy (after first dose and second dose)), CHILLS (chills (after first dose)/ chills (after second dose)), NAUSEA (nausea (after first dose)/ nausea (after second dose)) and PYREXIA (fever 101.7 (after first dose)/ fever 101.7 (after Second dose)). On an unknown date, the patient experienced FEELING ABNORMAL (I just don´t feel good (after second dose)). At the time of the report, ABDOMINAL PAIN UPPER (Very bad pain in my stomach in the right side (after first dose and second dose)), RETCHING (dry heave(after first dose)/ dry heave(after second dose)), PAIN (achy (after first dose)/ achy (after second dose)), FEELING ABNORMAL (I just don´t feel good (after second dose)), PRURITUS (very itchy (after first dose and second dose)), CHILLS (chills (after first dose)/ chills (after second dose)), NAUSEA (nausea (after first dose)/ nausea (after second dose)) and PYREXIA (fever 101.7 (after first dose)/ fever 101.7 (after Second dose)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Treatment information not provided.
shivers; fever; really terrible; This case was reported by a consumer and described the occurrence of shivers in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shivers, fever and feeling bad. On an unknown date, the outcome of the shivers, fever and feeling bad were unknown.   It was unknown if the reporter considered the shivers, fever and feeling bad to be related to Shingrix.  Additional case details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient was given the vaccine on Thursday afternoon from the day of reporting and since Thursday night the patient had shivers, fever and really terrible. No contact details were available.
Legs are like rubber; Soreness; Headache; Muscle Pain; Chills; Nausea; Vomiting; Pain at injection site; Tired; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Legs are like rubber), PAIN (Soreness), HEADACHE (Headache), MYALGIA (Muscle Pain) and CHILLS (Chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included HYDROCHLOROTHIAZIDE, ROSUVASTATIN CALCIUM (CRESTOR), CEFALEXIN (CEPHALEXINE) and CHYMOTRYPSIN, TRYPSIN (CHYMORAL [CHYMOTRYPSIN;TRYPSIN]) for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced LIMB DISCOMFORT (Legs are like rubber), PAIN (Soreness), HEADACHE (Headache), MYALGIA (Muscle Pain), CHILLS (Chills), NAUSEA (Nausea), VOMITING (Vomiting), VACCINATION SITE PAIN (Pain at injection site) and FATIGUE (Tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (Legs are like rubber) outcome was unknown and PAIN (Soreness), HEADACHE (Headache), MYALGIA (Muscle Pain), CHILLS (Chills), NAUSEA (Nausea), VOMITING (Vomiting), VACCINATION SITE PAIN (Pain at injection site) and FATIGUE (Tired) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Numbness around her mouth; She feels like not able to talk properly; Light headache after few hours of vaccine; feel like pass out; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (feel like pass out), DIZZINESS (Dizziness), HYPOAESTHESIA ORAL (Numbness around her mouth), SPEECH DISORDER (She feels like not able to talk properly) and HEADACHE (Light headache after few hours of vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced PRESYNCOPE (feel like pass out), DIZZINESS (Dizziness) and HEADACHE (Light headache after few hours of vaccine). On 13-May-2021, the patient experienced HYPOAESTHESIA ORAL (Numbness around her mouth) and SPEECH DISORDER (She feels like not able to talk properly). At the time of the report, PRESYNCOPE (feel like pass out), DIZZINESS (Dizziness), HYPOAESTHESIA ORAL (Numbness around her mouth), SPEECH DISORDER (She feels like not able to talk properly) and HEADACHE (Light headache after few hours of vaccine) outcome was unknown.            No relevant concomitant medications were provided. No treatment information was provided. The action taken for mRNA-1273 was not applicable.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient became dizzy after receiving vaccine and started to become unresponsive. Patient was helped to ground and the legs were elevated, within 10 seconds patient was responding to verbal ques and was back to 100% within 30  seconds. Patient was observed in a chair and given some water and saltine crackers for an additional 20 minutes. Patient stated he was ready to go at the end of the 20 minute wait period and left the pharmacy
Immediate Site pain,  headache after approx. 2 hrs,  chills, chest pain, shortness of breath after about 8 hours.  Chest pain continuing into next day